RANK-L inhibitor as a promising agent for refractory extensive craniofacial fibrous dysplasia: A case report.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 37823398.
- Also identified by DOI 10.1002/hed.27546 and PMC identifier 10843282.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
McCune-Albright syndrome is a rare disorder characterized by polyostotic fibrous dysplasia (FD), café-au-lait skin pigmentation, and endocrine dysfunction. Extensive FD in the craniofacial region can present significant challenges in terms of disease control and carries a high risk of permanent visual impairment. We present a case of medically and surgically resistant FD that required nine optic nerve decompressions. The condition was ultimately controlled with the use of the denosumab agent. The case highlights the importance and potential efficacy of denosumab in resistant FD management, particularly in cases involving sensitive organs.
Medical subject headings
- Craniofacial Fibrous Dysplasia
- Fibrous Dysplasia, Polyostotic